
New Survey Finds Healthcare Access and Affordability are Americans' Top Public Health Concern
Mar 14, 2025 01:50 am UTC| Business Health
The United States healthcare system is currently in a state of concern. The country is facing problems with the workforce shortage, an aging population, and a growing mental health crisis, which have all been exacerbated...

How the pandemic’s narratives are still unfolding, five years on
Mar 11, 2025 14:59 pm UTC| Insights & Views Health
Do you clearly remember the choices you made a few years ago during the early days of the COVID pandemic? Did you painstakingly wipe down your groceries before putting them away, quarantine your mail three days before...

Five years after the pandemic, the world is poorly prepared for another one
Mar 11, 2025 14:58 pm UTC| Insights & Views Health
In Europe ten people died from measles in 2024, and the US has had several major outbreaks. Bird flu has affected dairy herds in 17 US states from North Carolina to California and has just been reported in cats. So far, it...

5 years since COVID was declared a pandemic, we’re still poorly prepared for the next one
Mar 11, 2025 14:57 pm UTC| Insights & Views Health
On March 11, 2020, as COVID continued to spread rapidly around the globe, the World Health Organization (WHO) officially declared a pandemic. More than 7 million people have since died from COVID. The virus, and the public...

Mar 11, 2025 14:54 pm UTC| Insights & Views Life Health
Early brain development lays the foundation for lifelong health and success. But disruptions to a childs early environment can leave a long-lasting imprint on their development and success. For example, research shows that...

Are our thoughts ‘real’? Here’s what philosophy says
Mar 08, 2025 07:34 am UTC| Insights & Views Health
You can doubt just about anything. But theres one thing you can know for sure: you are having thoughts right now. This idea came to characterise the philosophical thinking of 17th century philosopher René Descartes....

FDA Reviews GSK’s Depemokimab for Asthma and CRSwNP Treatment
Mar 03, 2025 09:29 am UTC| Business Governance Health
The U.S. Food and Drug Administration (FDA) has accepted GlaxoSmithKlines (NYSE:GSK) biologics license application for depemokimab, an ultra-long-acting monoclonal antibody targeting interleukin-5 (IL-5). The drug is under...